Human sebaceous tumors harbor inactivating mutations in LEF1.
about
The CK1 Family: Contribution to Cellular Stress Response and Its Role in CarcinogenesisMore than one way to skin . .Scratching the surface of skin developmentAdult mammalian stem cells: the role of Wnt, Lgr5 and R-spondinsCell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentialsMeta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulationLithium chloride regulates the proliferation of stem-like cells in retinoblastoma cell lines: a potential role for the canonical Wnt signaling pathway.Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications.Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis.Loss of Mpzl3 function causes various skin abnormalities and greatly reduced adipose depotsInactivation of LEF1 in T-cell acute lymphoblastic leukemia.Lef1DeltaN binds beta-catenin and increases osteoblast activity and trabecular bone mass.OSTM1 regulates beta-catenin/Lef1 interaction and is required for Wnt/beta-catenin signaling.β-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors.Past visits present: TCF/LEFs partner with ATFs for β-catenin-independent activityTargeting serum glucocorticoid-regulated kinase-1 in squamous cell carcinoma of the head and neck: a novel modality of local controlIsotretinoin and FoxO1: A scientific hypothesis.Sebaceous neoplasia and Torre-Muir syndrome.Compartmentalized Epidermal Activation of β-Catenin Differentially Affects Lineage Reprogramming and Underlies Tumor Heterogeneity.Wnt signaling in skin development, homeostasis, and disease.Wnt signaling in bone formation and its therapeutic potential for bone diseases.Diversity of LEF/TCF action in development and disease.Hedgehog signaling, keratin 6 induction, and sebaceous gland morphogenesis: implications for pachyonychia congenita and related conditionsInvestigating the specific core genetic-and-epigenetic networks of cellular mechanisms involved in human aging in peripheral blood mononuclear cells.Functional Characterization of a Small-Molecule Inhibitor of the DKK1-LRP6 InteractionBad Hair Day: Testosterone and WntsDeciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice.Bone morphogenetic protein antagonist noggin promotes skin tumorigenesis via stimulation of the Wnt and Shh signaling pathways.Cutaneous Notch signaling in health and disease.Runx2 and bone morphogenic protein 2 regulate the expression of an alternative Lef1 transcript during osteoblast maturation.Differentiation of the sebaceous gland.Development and homeostasis of the sebaceous gland.Epidermal stem cells: an update on their potential in regenerative medicine.Epithelial stem cells in adult skin.Upward bound: follicular stem cell fate decisions.Induction of gene encoding FABP4 in Pten-null keratinocytes.Wnt signaling in skin homeostasis and pathology.Canonical and noncanonical Wnt signaling in neural stem/progenitor cells.Reprogramming adult dermis to a neonatal state through epidermal activation of β-catenin.Interfering with stem cell-specific gatekeeper functions controls tumour initiation and malignant progression of skin tumours.
P2860
Q21129297-75EBC77A-5328-4634-8108-1E0DB853CC39Q24646903-6DDA23FC-99AA-4734-85D9-224F24BF68BAQ24647707-C2D239F3-A46C-48EE-8D4F-4B7308FF3984Q26991478-C19A850E-933F-49C7-B66F-25ED856FF970Q27022532-99254073-C4C0-4F3A-BDEC-F9C9E7EB188CQ33316875-F54CBF32-D4FB-4F25-B657-BEEFA5038F01Q33523529-233932AF-3C92-46F8-A18B-C73939072D97Q33588064-22A1CCDF-18D0-4537-8CD4-514AF21EAD69Q33667612-546CE930-4AF5-4138-A5D2-E004E1B3BF98Q33756669-D26C191D-EAD9-44B2-9959-70D4C5523571Q33788690-D8A82C59-DF83-48BE-9FFA-F9A1C771500DQ34719382-7FFF5C76-2F4C-4AEF-8758-BC6428BEAD17Q34764254-20C61315-396E-469C-B614-4977E3FBA472Q34961818-27EDACFE-D5F9-464D-A10D-6224BFB648A6Q34962032-568287D5-1216-47D1-A562-6F7CD323FCDBQ35499408-4A2AAC9A-5D68-4B50-AD00-BF01FB3F6F05Q35558873-C4D170CC-9C2E-4F40-9985-FA7EB1E47FD5Q36248563-BF08F10D-FF32-443F-93E7-301CE6DBA425Q36465491-2B80E406-860E-4454-BCF2-FFC3175B62B0Q36555217-260AC8EC-69F9-4078-9A94-55FE1C981864Q36638647-70644F25-723B-4673-A8FC-707C4A33E18FQ36672669-218C4AC3-4744-43AC-BADA-3B10C3662625Q36855698-F97C70C9-A24A-4917-BDF4-CEBB887CFFB0Q36962345-4115FBA6-38DE-44AD-A93E-EDE051D06B41Q37005265-BBAD9441-06DD-4E82-87BA-8479F51D292BQ37036483-50DF27E6-5D04-4CCD-866B-0680D86F9CCCQ37259094-9BEDE244-E4E6-4627-9B9B-66276CDEAB7AQ37316577-28B96386-65CD-431E-BA7D-D68A3C3B25E7Q37340356-62D23FAF-5FA5-4F29-8D16-FA719249952BQ37418536-D60BB7E3-C592-4258-A767-9E5B7A5E99A4Q37708030-0D2A94E4-D5F8-4252-B2B0-5E6B9C48D914Q38041868-C8AEFD9C-B407-4089-8A74-28267B372D70Q38091752-54B341CC-088C-43D9-BB97-31939F82AEF0Q38179661-E90752AE-F162-47EF-9E46-8328E1F15905Q38254761-9AD6DC0E-3C7B-4C6E-B298-50B8C00A7BD7Q38355691-003CB127-E21F-4146-9F71-792E69D5635FQ38394678-F31A423C-8B6F-415B-AAB3-D5E95719EB81Q38573790-BC0E27A3-0C21-4442-83DF-4D321478CE83Q38979314-0AC1FF39-19A1-4E3F-B8AE-A6EF83492F2CQ39052075-C3A95FD7-97E9-4328-8F1A-84E7D8C603AF
P2860
Human sebaceous tumors harbor inactivating mutations in LEF1.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Human sebaceous tumors harbor inactivating mutations in LEF1.
@en
type
label
Human sebaceous tumors harbor inactivating mutations in LEF1.
@en
prefLabel
Human sebaceous tumors harbor inactivating mutations in LEF1.
@en
P2093
P2860
P356
P1433
P1476
Human sebaceous tumors harbor inactivating mutations in LEF1.
@en
P2093
Christos C Zouboulis
Hikaru Takeda
Stephen Lyle
P2860
P2888
P304
P356
10.1038/NM1386
P407
P577
2006-03-26T00:00:00Z